SP-0251 Implementation of new BSS in a radiotherapy department: Implications for medical physicists

SP-0033: Medical physicists will drive the development and implementation of artificial intelligence in Radiation Oncology

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)00059-1 ◽

2020 ◽

Vol 152 ◽

pp. S8

Author(s):

W. Van Elmpt ◽

N. Jornet

Keyword(s):

Artificial Intelligence ◽

Radiation Oncology ◽

Medical Physicists

Download Full-text

Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries

Strahlentherapie und Onkologie ◽

10.1007/s00066-016-1003-y ◽

2016 ◽

Vol 192 (8) ◽

pp. 507-515 ◽

Cited By ~ 3

Author(s):

David Krug ◽

Rene Baumann ◽

Thorsten Rieckmann ◽

Emmanouil Fokas ◽

Tobias Gauer ◽

...

Keyword(s):

Radiation Oncologists ◽

German Speaking ◽

Medical Physicists

Download Full-text

Structured mentorship program for the ABR international medical graduates alternate pathway for medical physicists in diagnostic imaging

Journal of Applied Clinical Medical Physics ◽

10.1002/acm2.13166 ◽

2021 ◽

Vol 22 (1) ◽

pp. 351-353

Author(s):

Francesco Ria ◽

Joshua M. Wilson ◽

Jeffrey Nelson ◽

Ehsan Samei

Keyword(s):

Diagnostic Imaging ◽

International Medical ◽

International Medical Graduates ◽

Mentorship Program ◽

Medical Graduates ◽

Alternate Pathway ◽

Medical Physicists

Download Full-text

EANM position paper on the role of radiobiology in nuclear medicine

European Journal of Nuclear Medicine and Molecular Imaging ◽

10.1007/s00259-021-05345-9 ◽

2021 ◽

Author(s):

An Aerts ◽

Uta Eberlein ◽

Sören Holm ◽

Roland Hustinx ◽

Mark Konijnenberg ◽

...

Keyword(s):

Nuclear Medicine ◽

Absorbed Dose ◽

Added Value ◽

External Irradiation ◽

Executive Summary ◽

Dose Rates ◽

Biological Responses ◽

Medical Physicists ◽

Radiation Induced

Executive SummaryWith an increasing variety of radiopharmaceuticals for diagnostic or therapeutic nuclear medicine as valuable diagnostic or treatment option, radiobiology plays an important role in supporting optimizations. This comprises particularly safety and efficacy of radionuclide therapies, specifically tailored to each patient. As absorbed dose rates and absorbed dose distributions in space and time are very different between external irradiation and systemic radionuclide exposure, distinct radiation-induced biological responses are expected in nuclear medicine, which need to be explored. This calls for a dedicated nuclear medicine radiobiology. Radiobiology findings and absorbed dose measurements will enable an improved estimation and prediction of efficacy and adverse effects. Moreover, a better understanding on the fundamental biological mechanisms underlying tumor and normal tissue responses will help to identify predictive and prognostic biomarkers as well as biomarkers for treatment follow-up. In addition, radiobiology can form the basis for the development of radiosensitizing strategies and radioprotectant agents. Thus, EANM believes that, beyond in vitro and preclinical evaluations, radiobiology will bring important added value to clinical studies and to clinical teams. Therefore, EANM strongly supports active collaboration between radiochemists, radiopharmacists, radiobiologists, medical physicists, and physicians to foster research toward precision nuclear medicine.

Download Full-text

Consent and information giving in radiotherapy

Journal of Radiotherapy in Practice ◽

10.1017/s146039690700619x ◽

2007 ◽

Vol 6 (4) ◽

pp. 217-223

Author(s):

Gillian Thompson

Keyword(s):

Health Professional ◽

Quality Care ◽

Good Practice ◽

Consent Forms ◽

Policy Model ◽

Information Giving ◽

Department Of Health ◽

Radiotherapy Department ◽

Consent To Treatment ◽

To Receive

AbstractThis paper explores some of the issues around implementing a consent policy within the radiotherapy department. Consent can be defined as a patient’s agreement for a health care professional to provide care. The NHS Plan1 highlighted the need for quality care centred around the patient and for changes in the way patients are asked to give their consent to treatment. This led to the Department of Health (DoH) publishing a Good Practice in Consent Implementation Guide (2001)2 for use within all NHS Trusts from 1 April 2002, which aimed to provide consistency across the NHS and provides a policy model and generic consent forms.The policy recommends that the health professional carrying out the procedure is ultimately responsible for ensuring that the patient is genuinely consenting to what is being done, as it is they who would be held responsible in law should a case be made by a patient against a health professional. In radiotherapy, it is the Clinical Oncologist who obtains consent as they are responsible for prescribing courses of treatment; however, it is the Radiographer’s role to deliver this treatment. This paper discusses some of the issues around implementing a consent policy in terms of who can give and confirm consent, and what are the requirements for training if the patient is to receive the appropriate information before making the decision to consent to treatment.

Download Full-text